Cryo Cell International (CCEL) Income from Continuing Operations (2010 - 2026)
Cryo Cell International (CCEL) reported Income from Continuing Operations of 47108.0 for Q1 2026, down 83.35% year-over-year from 282855.0 in Q1 2025, and up 101.23% quarter-over-quarter from 3817433.0 in Q4 2025.
Cryo Cell International (CCEL) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has 17 years of Income from Continuing Operations data on file, last reported at 47108.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 47108.0, down 83.35% year-over-year; the trailing twelve-month figure through Feb 2026 was 2665132.0 (down 2170.66% YoY), and the FY2025 annual result was 2429385.0, down 704.18% from the prior year.
- Income from Continuing Operations climbed to 47108.0 in Q1 2026 per CCEL's latest filing, from 3817433.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1051679.0 in Q3 2024 and troughed at 11190018.0 in Q4 2023.
- A 5-year average of 513555.47 and a median of 556241.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations plunged 1435.61% in 2023, then jumped 196.77% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 837822.0 in 2022, then sank by 1435.61% to 11190018.0 in 2023, then soared by 83.36% to 1861615.0 in 2024, then plunged by 105.06% to 3817433.0 in 2025, then jumped by 101.23% to 47108.0 in 2026.
- Business Quant data shows CCEL's Income from Continuing Operations at 47108.0 in Q1 2026, 3817433.0 in Q4 2025, and 749408.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 1.86 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 906.00 Mn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 275.04 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 232.30 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 99.76 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 358.68 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 68.68 Mn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 66.30 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 80.67 Mn |
| 10 | Cryo Cell International | 29.64 Mn | 26.74 Mn | 6.03 Mn | 47,108.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 47,108.00 |
| Nov 30, 2025 | -3.82 Mn |
| Aug 31, 2025 | 749,408.00 |
| May 31, 2025 | 355,785.00 |
| Feb 28, 2025 | 282,855.00 |
| Nov 30, 2024 | -1.86 Mn |
| Aug 31, 2024 | 1.05 Mn |
| May 31, 2024 | 655,790.00 |
| Feb 29, 2024 | 556,241.00 |
| Nov 30, 2023 | -11.19 Mn |
| Aug 31, 2023 | 680,561.00 |
| May 31, 2023 | 220,976.00 |
| Feb 28, 2023 | 766,812.00 |
| Nov 30, 2022 | 837,822.00 |
| Aug 31, 2022 | 466,820.00 |
| May 31, 2022 | 634,719.00 |
| Feb 28, 2022 | 832,047.00 |
| Nov 30, 2021 | -3.64 Mn |
| Aug 31, 2021 | 856,494.00 |
| May 31, 2021 | 1.17 Mn |